Chemerin levels are positively correlated with abdominal visceral fat accumulation

Clinical Endocrinology

Volumn 77, Issue 1, 2012, Pages 47-50

  Shin, Hyun Young ^a   Lee, Duk C ^a   Chu, Sang H ^b   Jeon, Justin Y ^b   Lee, Mi K ^b   Im, Jee A ^c   Lee, Ji Won ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University   (South Korea)

^c INTOTO Inc   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHEMERIN; CHOLESTEROL; CREATININE; INSULIN; TRIACYLGLYCEROL;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD PRESSURE; BODY COMPOSITION; BODY MASS; CARDIOMETABOLIC RISK; CHOLESTEROL BLOOD LEVEL; COMPUTER ASSISTED TOMOGRAPHY; CORRELATIONAL STUDY; CREATININE BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LIPID STORAGE; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; BODY COMPOSITION; CARDIOVASCULAR DISEASES; CHEMOKINES; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; OBESITY, ABDOMINAL; RISK FACTORS; TOMOGRAPHY SCANNERS, X-RAY COMPUTED; YOUNG ADULT;

EID: 84862011803     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2011.04217.x     Document Type: Article

References (19)

1. Wajchenberg, B.L. (2000) Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocrine Reviews, 21, 697-738.
2. Kersha w, E.E. & Flier, J.S. (2004) Adipose tissue as an endocrine organ. Journal of Clinical Endocrinology and Metabolism, 89, 2548-2556.
3. Bozaoglu, K., Bolton, K., McMillan, J. et al. (2007) Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology, 148, 4687-4694. (Pubitemid 47481514)
4. Goralski, K.B., McCarthy, T.C., Hanniman, E.A. et al. (2007) Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. Journal of Biological Chemistry, 282, 28175-28188. (Pubitemid 47529521)
5. Becker, M., Rabe, K., Lebherz, C. et al. (2010) Expression of human chemerin induces insulin resistance in the skeletal muscle but does not affect weight, lipid levels, and atherosclerosis in LDL receptor knockout mice on high-fat diet. Diabetes, 59, 2898-2903.
6. Bozaoglu, K., Segal, D., Shields, K.A. et al. (2009) Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population. Journal of Clinical Endocrinology and Metabolism, 94, 3085-3088.
7. Stejskal, D., Karpisek, M., Hanulova, Z. et al. (2008) Chemerin is an independent marker of the metabolic syndrome in a Caucasian population: a pilot study. Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc Czechoslovakia, 152, 217-221.
8. Lee, J.W., Lee, H.R., Shim, J.Y. et al. (2007) Viscerally obese women with normal body weight have greater brachial-ankle pulse wave velocity than nonviscerally obese women with excessive body weight. Clinical Endocrinology (Oxford), 66, 572-578.
9. Sell, H., Laurencikiene, J., Taube, A. et al. (2009) Chemerin is a novel adipocyte-derived factor insulin resistance in primary human skeletal muscle cells. Diabetes, 58, 2731-2740.
10. Ernst, M.C., Issa, M., Goralski, K.B. et al. (2010) Chemerin exacerbates glucose intolerance in mouse models of obesity and diabetes. Endocrinology, 151, 1998-2007.
11. Srdic, B., Stokic, E., Polzovic, A. et al. (2005) Abdominal adipose tissue - significance and methods of detection. Medicinski Pregled, 58, 258-264.
12. Mussig, K., Staiger, H., Machicao, F. et al. (2009) RARRES2, encoding the novel adipokine chemerin, is a genetic determinant of disproportionate regional body fat distribution: a comparative magnetic resonance imaging study. Metabolism, 58, 519-524.
13. Weigert, J., Neumeier, M., Wanninger, J. et al. (2010) Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes. Clinical Endocrinology, 72, 342-348.
14. Yang, M., Yang, G., Dong, J. et al. (2010) Elevated plasma levels of chemerin in newly diagnosed type 2 diabetes mellitus with hypertension. Journal of Investigative Medicine, 58, 883-886.
15. Wittamer, V., Franssen, J.D., Vulcano, M. et al. (2003) Specific recruitment of antigenpresenting cells by chemerin, a novel processed ligand from human inflammatory fluids. Journal of Experimental Medicine, 198, 977-985. (Pubitemid 37248614)
16. Parolini, S., Santoro, A., Marcenaro, E. et al. (2007) The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. Blood, 109, 3625-3632. (Pubitemid 46641708)
17. Lehrke, M., Becker, A., Greif, M. et al. (2009) Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis. European Journal of Endocrinology, 161, 339-344.
18. Yoshimura, T. & Oppenheim, J.J. (2008) Chemerin reveals a chimeric nature. Journal of Experimental Medicine, 205, 2187-2190.
19. Cash, J.L., Hart, R., Russ, A. et al. (2008) Synthetic chemerin-derived peptides suppress inflammation through ChemR23. Journal of Experimental Medicine, 205, 767-775. (Pubitemid 351549876)